Keisuke Hirota
Overview
Explore the profile of Keisuke Hirota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirota K, Salim F, Yamada T
Bioinformatics
. 2025 Feb;
41(3).
PMID: 39909853
Motivation: Progress in sequencing technology has led to determination of large numbers of protein sequences, and large enzyme databases are now available. Although many computational tools for enzyme annotation were...
2.
Kawaguchi T, Kawaguchi A, Hashida R, Nakano D, Tsutsumi T, Kawaguchi M, et al.
J Gastroenterol
. 2023 Dec;
59(3):216-228.
PMID: 38159112
Background: Exercise, particularly resistance exercise, is beneficial for sarcopenia in patients with liver cirrhosis. However, the effects of exercise on events remain unclear. We aimed to examine the effects of...
3.
Otsubo R, Hashida R, Murotani K, Iwanaga S, Hirota K, Koya S, et al.
Sci Rep
. 2023 Aug;
13(1):13909.
PMID: 37626144
Lumbar spinal stenosis (LSS) can interfere with daily life and quality of life (QOL). Evaluating physical function and QOL and helping patients to improve is the focus of rehabilitation. Phase...
4.
Tanaka T, Miwa K, Shimotsuura Y, Nagasu S, Shigyou H, Hirota K, et al.
J Gastroenterol Hepatol
. 2023 May;
38(10):1760-1767.
PMID: 37225648
Background: Nivolumab extends the overall survival (OS) of patients with advanced gastric cancer (AGC). Intramuscular adipose tissue (IMAT) is associated with the prognosis of patients with various cancers. We investigated...
5.
Hashida R, Nakano D, Matsuse H, Yoshio S, Tsutsumi T, Kawaguchi M, et al.
JGH Open
. 2023 Mar;
7(3):231-234.
PMID: 36968574
We developed a low-intensity 10-min resistance exercise program for nonalcoholic fatty liver disease (NAFLD). We report a case of NAFLD with elevated hepatic fibrosis indices, which were improved by a...
6.
Sakai M, Kawaguchi T, Koya S, Hirota K, Matsuse H, Torimura T
Kurume Med J
. 2022 Sep;
67(2.3):97-105.
PMID: 36130884
Objective: Trunk muscle mass can be evaluated by skeletal muscle index (SMI), which is a prognostic factor in patients with hepatocellular carcinoma (HCC); however, this requires the use of computed...
7.
Shimose S, Koya S, Kawaguchi T, Hirota K, Yoshio S, Niizeki T, et al.
Clin Mol Hepatol
. 2021 Sep;
27(4):616-619.
PMID: 34517441
No abstract available.
8.
Hashida R, Matsuse H, Kawaguchi T, Yoshio S, Bekki M, Iwanaga S, et al.
Hepatol Res
. 2021 May;
51(7):823-833.
PMID: 34014020
Aims: Exercise is effective for the prevention of liver cancer. Exercise exerts biological effects through the regulation of microRNAs (miRNAs) and cytokines/myokines. We aimed to investigate the effects of low-intensity...
9.
Hirota K, Matsuse H, Koya S, Hashida R, Bekki M, Yanaga Y, et al.
Phys Ther Res
. 2021 May;
24(1):69-76.
PMID: 33981529
Objective: Muscle atrophy is associated with autologous stem cell transplantation (ASCT)-related outcomes in patients with malignant lymphoma (ML). However, the impact of ASCT on muscle mass remains unclear in patients...
10.
Kamachi N, Shimose S, Hirota K, Koya S, Iwamoto H, Niizeki T, et al.
Mol Clin Oncol
. 2021 Mar;
14(4):79.
PMID: 33758660
Severe ascites is an adverse event of ramucirumab (RAM), a second-line treatment for hepatocellular carcinoma (HCC). Ascites can be associated with various factors, including nutritional status and muscle quality. The...